Neovacs - Regulated information

FR
EN

Subscribe to all NEOVACS financial information by registering here.

Inside Information: other releases

2017/12/12 6:00PM

NEOVACS ANNOUNCES POSITIVE RESULTS OF PRECLINICAL STUDY FOR IFNA KINOID IN TYPE 1 DIABETES

2017/11/28 6:00PM

Neovacs announces freeallocations of redeemable share warrants to all company's shareholders and the strengthening of its cash position by issuing EUR 5.15 million inconvertible bonds

2017/10/27 6:00PM

NEOVACS PROVIDES BUSINESSUPDATEAND ANNOUNCES HALF-YEAR 2017 FINANCIAL RESULTS

2017/07/31 6:00PM

NEOVACS SUCCESSFULLY RAISES EUR 6.0 MILLION IN PRIVATE PLACEMENT WITH U.S.BIOTECHNOLOGY INSTITUTIONAL INVESTORS

2017/07/11 6:00PM

Neovacs Announces Positive IDSMB Review for Phase IIb Clinical Trial of IFNA Kinoid in Lupus

2017/07/05 6:00PM

NEOVACS ANNOUNCES LICENSE AGREEMENT FOR IFNA KINOID FOR TREATMENT OF LUPUS IN TURKEY

2017/06/20 6:00PM

NEOVACS ANNOUNCES THE COMPLETION OF PATIENT ENROLLMENT IN PHASE IIB CLINICAL STUDY OF IFNA Kinoid INLUPUS

2017/06/01 6:00PM

USE OF EQUITY LINE

2017/05/10 6:00PM

NEOVACS AND LUPUS EUROPE JOIN VOICES ON WORLD LUPUS DAY

2017/05/04 6:00PM

NEOVACS TO PRESENT CLINICAL DEVELOPMENT UPDATE ON IFNA KINOID IN DERMATOMYOSIS

2017/03/30 6:00PM

NEOVACS PROVIDES CORPORATE UPDATE AND REPORTS FULL YEAR 2016 FINANCIAL RESULTS

2017/03/10 6:00PM

NEOVACS ISSUED NEW BROAD PATENT IN CHINA FOR IFNA KINOID

2017/03/10 6:00PM

NEOVACS AND BIOSENSE SIGN OPTION AGREEMENT WORTHUP TO EUR 65 MILLION PLUS ROYALTIES FOR CHINESE DEVELOPMENT AND COMMERCIAL RIGHTS TO IFNA KINOID FOR LUPUS AND DERMATOMYOSITIS

2017/01/31 6:00PM

NEOVACS REPORTS FIRST POSITIVE IMMUNOGENICITY RESULTS FOR IFNA KINOID IN MODEL OF TYPE 1 DIABETES

Total number of voting rights and capital: Information on the total number of voting rights and shares making up the share capital

2017/12/31 6:00PM

Number of voting rights and shares as of December 31, 2017

2017/12/31 6:00PM

Number of voting rights and shares as of December 31, 2017

2017/11/30 6:00PM

Number of voting rights and shares as of November 30, 2017

2017/10/31 6:00PM

Number of voting shares and rights as of october 31, 2017

2017/10/31 6:00PM

Number of voting shares and rights as of october 31, 2017

2017/09/30 6:00PM

Number of shares and voting rights as of September 30, 2017

2017/08/31 6:00PM

Number of voting rights and shares as of August 31, 2017

2017/07/30 6:00PM

Number of voting rights and shares as of July 30, 2017

2017/06/30 6:00PM

Number of voting rights and shares as of June 30, 2017

2017/06/30 6:00PM

Number of voting rights and shares as of June 30, 2017

2017/05/31 6:00PM

Number of voting righs and shares as of May 31, 2017

2017/04/30 6:00PM

Number of voting rights and shares as April 30, 2017

2017/01/31 6:00PM

Number of voting rights and shares as of January 31, 2017

The publication history is accessible from the official French centralized storage mechanism regulated information www.info-financiere.fr.

Each PDF has been scanned by antimalware and incorporates a SECURITY MASTER Footprint. To check its authenticity:
www.security-master-footprint.com

Party powered automatically by Actusnews Wire ©
(Primary Information Provider)